Merrimack Pharmaceuticals, Inc. (MACK): Price and Financial Metrics

Merrimack Pharmaceuticals, Inc. (MACK): $15.13

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add MACK to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#150 of 360

in industry

MACK Price/Volume Stats

Current price $15.13 52-week high $15.89
Prev. close $15.13 52-week low $11.53
Day low $15.13 Volume 1,255,700
Day high $15.17 Avg. volume 171,217
50-day MA $14.81 Dividend yield N/A
200-day MA $13.37 Market Cap 223.74M

MACK Stock Price Chart Interactive Chart >


Merrimack Pharmaceuticals, Inc. (MACK) Company Bio


Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. The company was founded in 1993 and is based in Cambridge, Massachusetts.


MACK Latest News Stream


Event/Time News Detail
Loading, please wait...

MACK Latest Social Stream


Loading social stream, please wait...

View Full MACK Social Stream

Latest MACK News From Around the Web

Below are the latest news stories about MERRIMACK PHARMACEUTICALS INC that investors may wish to consider to help them evaluate MACK as an investment opportunity.

Merrimack Reports Third Quarter 2023 Financial Results

CAMBRIDGE, Mass., November 02, 2023--Merrimack Reports Third Quarter 2023 Financial Results

Yahoo | November 2, 2023

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) most popular amongst retail investors who own 39% of the shares, institutions hold 33%

Key Insights Significant control over Merrimack Pharmaceuticals by retail investors implies that the general public has...

Yahoo | September 26, 2023

Merrimack Reports Second Quarter 2023 Financial Results

CAMBRIDGE, Mass., August 03, 2023--Merrimack Reports Second Quarter 2023 Financial Results

Yahoo | August 3, 2023

Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Can Afford To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Merrimack...

Yahoo | July 3, 2023

Merrimack Reports First Quarter 2023 Financial Results

CAMBRIDGE, Mass., May 04, 2023--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [("Merrimack" or the "Company")] today announced its first quarter 2023 financial results for the period ended March 31, 2023.

Yahoo | May 4, 2023

Read More 'MACK' Stories Here

MACK Price Returns

1-mo 0.20%
3-mo 3.21%
6-mo 14.27%
1-year 20.65%
3-year 135.30%
5-year 163.59%
YTD 12.83%
2023 17.02%
2022 193.09%
2021 -43.25%
2020 118.73%
2019 -18.39%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!